tiprankstipranks
Citius Oncology, Inc. (CTOR)
NASDAQ:CTOR
US Market
CTOR
Citius Oncology
RESEARCH TOOLSreports
Want to see CTOR full AI Analyst Report?

Citius Oncology (CTOR) Income Statement

131 Followers

Citius Oncology Income Statement

Last quarter (Q1 2026), Citius Oncology's total revenue was $3.94M, an increase of Infinity% from the same quarter last year. In Q1, Citius Oncology's net income was $-5.53M. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 23.52M$ 20.57M$ 12.12M$ 9.71M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 9.71M
EBITDA
$ -23.49M$ -20.57M$ -12.12M$ 0.00
Operating Income
$ -23.52M$ -20.57M$ -12.12M$ -9.71M
Other Income/Expenses
$ -181.66K$ 0.00$ 0.00$ 0.00
Pretax Income
$ -23.70M$ -20.57M$ -12.12M$ -9.71M
Net Income
$ -24.76M$ -21.15M$ -12.70M$ -10.87M
Per Share Metrics
Basic EPS
$ -0.34$ -0.30$ -0.19$ -0.08
Diluted EPS
$ -0.34$ -0.30$ -0.19$ -0.08
Weighted Average Shares Outstanding
 73.27M 71.55M 89.48M 90.16M
Weighted Average Shares Outstanding (Diluted)
 73.27M 71.55M 89.48M 90.16M
Currency in USD

Citius Oncology Earnings and Revenue History